Hailey-Hailey Disease is Associated with Diabetes: A Population-based Cohort Study, Clinical Cohort Study, and Pedigree Analysis.
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
08
03
2023
accepted:
27
09
2023
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
Hailey-Hailey disease is a rare hereditary skin disease caused by mutations in the ATP2C1 gene encoding the secretory pathway Ca2+/Mn2+-ATPase 1 (SPCA1) protein. Extracutaneous manifestations of Hailey-Hailey disease are plausible but still largely unknown. The aim of this study was to explore the association between Hailey-Hailey disease and diabetes. A population-based cohort study of 347 individuals with Hailey-Hailey disease was performed to assess the risks of type 1 diabetes and type 2 diabetes, using Swedish nationwide registries. Pedigrees from 2 Swedish families with Hailey-Hailey disease were also investigated: 1 with concurrent type 1 diabetes and HLA-DQ3, the other with type 2 diabetes. Lastly, a clinical cohort with 23 individuals with Hailey-Hailey disease and matched healthy controls was evaluated regarding diabetes. In the register data males with Hailey-Hailey disease had a 70% elevated risk of type 2 diabetes, whereas no excess risk among women could be confirmed. In both pedigrees an unusually high inheritance for diabetes was observed. In the clinical cohort, individuals with Hailey-Hailey disease displayed a metabolic phenotype indicative of type 2 diabetes. Hailey-Hailey disease seems to act as a synergistic risk factor for diabetes. This study indicates, for the first time, an association between Hailey-Hailey disease and diabetes and represents human evidence that SPCA1 and the Golgi apparatus may be implicated in diabetes pathophysiology.
Identifiants
pubmed: 38014829
doi: 10.2340/actadv.v103.10436
pmc: PMC10695124
doi:
Substances chimiques
Calcium-Transporting ATPases
EC 7.2.2.10
ATP2C1 protein, human
EC 7.2.2.10
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv10436Références
Ann Dermatol. 2018 Jun;30(3):265-275
pubmed: 29853739
Diabet Med. 2020 Oct;37(10):1723-1727
pubmed: 31390484
J Am Acad Dermatol. 2019 Dec;81(6):1425-1426
pubmed: 31163229
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38
pubmed: 34964875
Lancet. 2018 Jun 16;391(10138):2449-2462
pubmed: 29916386
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14074-9
pubmed: 16966600
Genes (Basel). 2015 Mar 12;6(1):87-123
pubmed: 25774817
Am J Med. 2003 Apr 15;114(6):438-44
pubmed: 12727576
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1204-13
pubmed: 15336968
Biofactors. 2011 May-Jun;37(3):150-8
pubmed: 21674634
Curr Opin Immunol. 2016 Dec;43:60-66
pubmed: 27718448
Pediatr Diabetes. 2020 Mar;21(2):259-265
pubmed: 31702838
J Biol Chem. 2005 Mar 11;280(10):9467-73
pubmed: 15623514
Am J Clin Dermatol. 2020 Feb;21(1):49-68
pubmed: 31595434
Mol Genet Genomic Med. 2021 Feb;9(2):e1580
pubmed: 33345454
Curr Diab Rep. 2011 Dec;11(6):533-42
pubmed: 21912932
Nat Rev Nephrol. 2023 Mar;19(3):168-184
pubmed: 36316388
Eur J Epidemiol. 2017 Sep;32(9):765-773
pubmed: 28983736
J Appl Genet. 2020 May;61(2):187-193
pubmed: 31983024
Endocrinology. 2020 Feb 1;161(2):
pubmed: 31796960
Diabetes. 2020 Nov;69(11):2364-2376
pubmed: 32820009
Mol Aspects Med. 2015 Apr;42:105-18
pubmed: 25579745
Cell Calcium. 2006 Nov-Dec;40(5-6):539-51
pubmed: 17030367
J Clin Endocrinol Metab. 2007 Jun;92(6):2017-29
pubmed: 17389701
Diabetes Care. 2021 Nov;44(11):2449-2456
pubmed: 34670785
J Biol Chem. 2007 Sep 7;282(36):26517-27
pubmed: 17597066
Diabetes. 2018 Nov;67(11):2389-2396
pubmed: 30131390
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R67-74
pubmed: 16651371
Diabetol Metab Syndr. 2020 Feb 05;12:12
pubmed: 32042314
Diabetes. 1987 Jan;36(1):93-9
pubmed: 3792666
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213